Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Regulatory News
State Council Withdraws Numerous Administrative Approval Requirem... 9/29/2017
CDE Solicits Public Comments on Guidelines for Clinical Research ... 9/26/2017
CDE Publicizes Batch 23 of Drug Applications To Be Granted Priori... 9/26/2017
CFDA Vice Minister Outlines Drug Regulatory System Reform Progres... 9/25/2017
CDE Issues New Technical Standards for Generic Drug Equivalence D... 9/22/2017
National MR Filing System under Development by the CFDA 9/21/2017
CFDA Solicits Comments on Draft Announcement for Amendment of Dru... 9/13/2017
CFDA Issues New Announcement (2017#109) for Clinical Data Self-In... 9/13/2017
CFDA Issues Technical Guidelines for TCM Post Marketing Productio... 9/11/2017
CFDA Announce Order for Switch of Three OTC Topical Drugs to Pres... 9/10/2017
NIFDC and IIVS Sign MOU to Bring Non-Animal Test Methods to China... 9/9/2017
CDE Seeks Public Comments on Draft Research Guidelines for Post M... 9/7/2017
CFDA Issues Acceptance and Review Guides for Generic Drug Equival... 9/6/2017
CFDA Announces New Dossier and Stability Study Requirements for S... 9/6/2017
CDE Solicits Framework Comments on the Chinese Orange Book 9/4/2017
CDE Publicizes Batch 22 of Drug Applications To Be Granted Priori... 9/4/2017
Speech by CFDA Minister Bi Jingquan at the Inaugurating Conferenc... 9/4/2017
CFDA and NHFPC Issue Joint Notice to Strengthen Regulation and Pr... 9/1/2017
CFDA Solicits Comments on Rules for Overseas Drug Inspections 8/31/2017
Preparation of the Chinese Pharmacopoeia 2020 Began with CFDA Ann... 8/30/2017
CFDA Issues Guideline for Chemical Drug Manufacturing Process Cha... 8/29/2017
CFDA Issues Announcement for Relevant Matters of Generic Drug Equ... 8/28/2017
CFDA Solicits Comments on Draft Drug Data Management Guideline 8/28/2017
CDE Solicits Comments over Sale of BE Study Drug Samples 8/25/2017
CFDA Issues Notice to Advance MAH Trial 8/23/2017
CFDA Issues Policies for Handling of Food and Drug Violations and... 8/22/2017
CFDA Issues Technical Guidelines for Pharmacokinetic / Pharmacody... 8/22/2017
CDE Solicits Public Comments on Three Technical Guidelines 8/21/2017
CFDI to Initiate Clinical Data Inspection of 32 Drug Products (#1... 8/18/2017
CFDA Issues Announcement to Clarify Over Published Reference Drug... 8/18/2017
Page:2/8    Total number of articles:212  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links